Home › Funds › ADAR1 Capital Management, LLC › MNPR

ADAR1 Capital Management, LLC position in MNPR

MONOPAR THERAPEUTICS INC · Health Care

ADAR1 Capital Management, LLC reported holding 217,595 shares of MNPR (MONOPAR THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$20.1M, representing 1.12% of its reported portfolio and ranking #20 among its reported holdings. ADAR1 Capital Management, LLC has disclosed MNPR holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)217.59K sh
Reported value held$20.15M
Portfolio Weight1.12%
First reportedQ4 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How ADAR1 Capital Management, LLC's MNPR position evolved

ADAR1 Capital Management, LLC first disclosed a stake in MNPR in Q4 2024 at 130,037 shares (US$2.9M). The position peaked in Q2 2026 at 217,595 shares, worth US$20.1M. Across 7 filings, ADAR1 Capital Management, LLC increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 217,595 shares valued at US$20.1M — a reduction of -46,683 shares quarter over quarter.. Notable position changes include a 29% increase in Q3 2025 (shares fell 20% over the following quarter), a 80% increase in Q4 2025 (shares fell 16% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 130.04K $2.86M New
Q1 2025 100.77K $3.67M Reduce
Q2 2025 100.97K $3.61M Hold
Q3 2025 130.00K $10.62M Add
Q4 2025 233.91K $15.27M Add
Q1 2026 264.28K $14.48M Add
Q2 2026 217.59K $20.15M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MNPR and 13F data

MNPR (MONOPAR THERAPEUTICS INC) is a Health Care company. 84 other funds we track also report a position in MNPR — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$61.8M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$30.0M), Saturn V Capital Management LP (US$28.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MNPR

All MNPR fund holders →

FAQ

How long has ADAR1 Capital Management, LLC held MNPR?

ADAR1 Capital Management, LLC has disclosed MNPR holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is ADAR1 Capital Management, LLC's current position in MNPR?

As of Q2 2026, ADAR1 Capital Management, LLC holds 217.59K shares of MNPR (MONOPAR THERAPEUTICS INC), valued at $20.15M, representing 1.12% of its reported portfolio and ranking #20.

Has ADAR1 Capital Management, LLC been buying or selling MNPR?

In the latest 13F filing (Q2 2026), ADAR1 Capital Management, LLC reduced its position in MNPR. The position peaked in Q2 2026 at 217.59K shares.

Which other funds hold MNPR?

Other major institutional holders of MNPR include RA CAPITAL MANAGEMENT, L.P., DEERFIELD MANAGEMENT COMPANY, L.P., Saturn V Capital Management LP, among 84 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.